|
May 6
|
Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference
|
|
May 2
|
Edwards Lifesciences (NYSE:EW) Receives FDA Approval For Groundbreaking TAVR Therapy For Asymptomatic Patients
|
|
May 1
|
FDA approves Edwards’ TAVR system for asymptomatic aortic stenosis patients
|
|
May 1
|
Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis
|
|
May 1
|
Edwards Lifesciences Corporation (EW): Jim Cramer Says It’s a Hold — But Is Boston Scientific Now His Favorite?
|
|
Feb 25
|
Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference
|
|
Feb 20
|
Should Edwards Lifesciences Stock Remain in Your Portfolio Now?
|
|
Feb 16
|
The three-year loss for Edwards Lifesciences (NYSE:EW) shareholders likely driven by its shrinking earnings
|
|
Feb 12
|
Edwards Makes A Bullish Move As Heart-Valve Replacements Top $1 Billion
|
|
Feb 12
|
Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength
|
|
Feb 12
|
Q4 2024 Edwards Lifesciences Corp Earnings Call
|
|
Feb 12
|
Is Edwards Lifesciences Corporation (EW) the Best Medical Device Stock to Buy?
|
|
Feb 12
|
Edwards Lifesciences (NYSE:EW) Is Reinvesting At Lower Rates Of Return
|
|
Feb 12
|
Edwards predicts second-half lift from TAVR label expansion
|
|
Feb 12
|
Edwards Lifesciences Corp (EW) Q4 2024 Earnings Call Highlights: Strong Full-Year Growth and ...
|
|
Feb 11
|
Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics
|
|
Feb 11
|
Edwards Lifesciences Reports Fourth Quarter Results
|
|
Feb 10
|
Edwards Lifesciences (EW) Reports Q4: Everything You Need To Know Ahead Of Earnings
|
|
Jan 3
|
Edwards Lifesciences price target raised to $75 from $69 at Evercore ISI
|
|
Jan 2
|
Top 10 medtech deals of 2024
|